Publication date: Dec 22, 2025
This study aimed to identify the proportion of patients with vitiligo reporting new-onset disease or changes in disease status following COVID-19 vaccination or infection using an online survey. Among 114 respondents, over half reported no new-onset vitiligo or a change in vitiligo status following COVID-19 vaccination or infection; however, a sizeable minority reported worsening of vitiligo, smaller numbers reported new-onset disease, and few reported improvement. Larger studies are needed to clarify whether these associations are coincidental or reflect underlying pathological processes.
| Concepts | Keywords |
|---|---|
| Australas | 2019‐nCoV vaccine mRNA‐1273 |
| Covid | BNT162 vaccine |
| Dermatol | ChAdOx1 nCoV‐19 |
| Vaccination | COVID‐19 |
| Worsening | COVID‐19 vaccines |
| SARS‐CoV‐2 | |
| vitiligo |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | Vitiligo |
| disease | MESH | COVID-19 |
| disease | MESH | Infection |
| disease | MESH | pathological processes |
Original Article
(Visited 1 times, 1 visits today)